Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07147192 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Feasibility Study of an Accommodating IOL Design

StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Enrollment closed, study ongoing
    • Primary completion moved earlier from Jul 2027 to Oct 2026
    • Study completion moved earlier from Jan 2028 to Oct 2026
    • Site details revised at 4 of 4 sites
    v8
  2. Primary completion pushed from Apr 2027 to Jul 2027
    • Study completion pushed from Nov 2027 to Jan 2028
    • Study sites: 5 to 4
    v7
  3. Site details revised at 1 of 5 sitesv6
  4. Primary completion date: Jan 2027 to Apr 2027
    • Study completion date: Sep 2027 to Nov 2027
    v5
  5. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Dec 2025 to Dec 3, 2025
    • Site details revised at 5 of 5 sites
    v4
Show 2 earlier versionsHide 2 earlier versions
  1. Study sites: 4 to 5
    • Start date: Nov 2025 to Dec 2025
    v3
  2. Re-verified, no change to tracked fieldsv2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Alcon Research
30 trials monitored
See 3 trials at risk
The purpose of this clinical study is to assess safety and explore usability and effectiveness of the test product, AAL-FAIOL. This study will be conducted in Central America.
Trial Details
NCT Number NCT07147192
Lead Sponsor Alcon Research
Conditions
(from sponsor)		 Aphakia
Related terms Aphakia, Cataract
Enrollment 85 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov